Login   Contact Us      
RemitDATA - Gets what coming to you

Improve Your Reimbursement Results

Serum versus Plasma

Take Control of Your Medicare A/R

Staff Feedback Pays Dividends

Boost Cash Flow by Tracking DSO

Pharmacy Quality Standards

Billing Specialists Get The Job Done

Should you Part D

The Right Team Makes A Great Company

The Importance of Proper Aseptic Technique

The Answers Are in Your Data

Synercid

Inside the 835 - Part 1 - CR Codes

Treating an Unhealthy Accounts Receivable

Are You Compounding or Manufacturing?

Prepare For Bad Debt Reserves

Maximizing Your Value in Mergers and Acquisitions

Is Outsourcing Right For You?

Team Talent is Essential

What's the Value of Your Business

Inside the 835: Part 2--Medicare Codes

Pharmacists Recognized As A Provider:

Part D Success Story: $24K Denied, Then Reversed

Maximize Revenue On Rental Equipment

Leverage Points: Mission and Vision

The Value of Therapeutic Drug Monitoring

Listserv Lessons: Post-dose Vancomycin peak draws

Take Control of Your Patient Receivables

Acquisition Strategy – Securing Management

Pedigree Provisions: A New Responsibility

Cash is still King

Listserv Lessons: Patient Financial Responsibility

HEMOLYSIS - CAUSE AND EFFECT

Who's tracking YOUR sales?

Five Approaches to Training a Sales Person

CASH FLOW: Shows Your Company’s True Health

NPI Deadline is May 23 - Are you ready?

Listserv Lessons: Billing Per Diems on Non-Infused

Microalbumin

Credit Balances, an overlooked problem

Managing Open Invoices

Listserv Lessons: Insurance Company defining AWP

Revenue Recognition: Are You Collecting 95%?

BitLeap's online, offsite data backup system

Is NHIC getting The Job Done?

Drug of the Month - Infliximab

Sed.Rate and C-Reative Protein Assay

A Systemic Approach to Purchasing Negotiations

A Systemic Approach to Purchasing Negotiations 2

Practical Approach to Physician Credentialing

Is Noridian Getting The Job Done?

The Pharmacist’s Awareness of “Drug Induced Diseas

Listserv Lessons: Medicare Billing Split between M

Glycosylated Hemoglobin

Drug of the Month – Daptomycin (Cubicin®)

Using Denial Tracking to Improve Cash Flow and Sta

Dealing with Denial Code 204 (Replacment for PR 96

The Medicare Program: A Brief Overview

ListServ Lessons: Power PICC Flushing Protocols

Can a blood test predict a heart attack?

Software Implementations - do it perfect the first

Drug of the Month – Lynezolid (Zyvox®)

Add a second monitor to your laptop / desktop

Software implementations – it’s a great time to be

Extreme Drug-Resistant Tuberculosis

Listserv Lessons: Home Infusion Pharmacy vs Specia

Patient Satisfaction Scores

Managing your payer pricing files

Leadership: An Analysis

Listserv Lessons: Enteral Practice Standards

MRSA on the Rise

Using Clinicians to Improve Reimbursement

Software Implementations: Multi-site conversions

System Management: Managing Serialized Inventory

So, you have a payer contract…or do you?

Questions and Answers about Lyme Disease

Listserv Lessons: Timely Filing and Patient Debt O

System Implementation: 5 Phases of Information Sy

Managing your Windows Desktop

Insurance Companies Play to Win ... you should too

Blood Culture Contamination

KVO’s on Intermittent Pump Infusions

So, the nice lady at Medicare told you that it wou

Listserv Lessons: Huber Needle Changes

ListServ Lessons: Compounding Question

How many billers necessary to change a light bulb?

Listserv Lessons: Monitoring Shipping

Use of Routine ABNs

Investigating Reimbursement Issues

Repackaging your managed care strategy

Managing your Shared Contract Files

Stale A/R on Legacy Systems – Is It Really Worth I

ListServ Lessons - Infusion of Specialty Meds

Know Who Your Patients Are and Where They Are Comi

Know who your patients are and where they are comi

Patient Pay Accounts - If you can't measure it, yo

Those Pesky Rascals

The Care and Feeding of Your Item Master File

Billing Staff Measurement and Feedback

This Call May be Monitored for Quality Assurance

The Price is Right…Or Maybe Not

Using Time & Motion Studies to Improve Pharmacy Pr

Repackaging your managed care strategy

By Russell Gay
Friday, June 20, 2008

Repackaging your managed care strategy

Our family had just gotten back from a weekend at a Renaissance Fair and our six year old couldn’t wait to tell his friends about his adventures while at school Monday. That evening he told us that he shared stories about the knights jousting, shooting a bulls-eye with an arrow and being knighted Sir Chris by the King. But he lamented that “no one bows down to me”.

Despite all of our regal qualities, taking fragile patients home early from the hospital, providing educational or follow-up visits without reimbursement; it seems we don’t get much respect from payors.

Many of us remember the Roaring 80s and 90s when we heroically introduced health plans to the concept of home infusion therapy, we negotiated great rates, patients went home early and had great outcomes, health plans saved millions compared to hospital charges…everyone won.

That was then. The health plan now relegates us to the overwhelmed ancillary provider department who also contracts for sleep clinics, MRI centers, home health, DME, anything else that is not physician or hospital based. How do we break through the trend of shrinking reimbursement and commodious Par contracts?

We need to repackage our managed care strategy and our reimbursement. Why? Executives at health plans tell me that they view the current infusion therapy industry model as built around utilization. Incremental visits mean more nursing costs, more drugs, and more money from their premium dollars. All of the risk falls on the payor, whether they are the patient, employer and/or health plan. Due to recent high expenses, Health plans will now sit down with us if we present risk sharing agreements. Case rate, Cap Rate and Pay for Performance proposals are ideal if you are efficient and expert in your market for high-cost niches. Deals like this are common place outside of ancillary lines and health plans are receptive to these types of more exclusive partnerships.

Consider the following managed care strategies as you develop your proposals and meet with managed care executives:

1. Build your Case Rate proposal around your company's greatest clinical strengths. For example, acute & chronic pediatric programs in the home brings outstanding outcomes when administered by experienced pediatric nurses. Here is some insider information: Children Hospital Per Diems are the highest that Health Plans pay, show them how to take these patients home early and you will win a preferred contract and a new partner.

2. Connect with the CFO at your local acute care facility that has an Emergency Room. Hospital ERs are huge money loosers for facilities and a major concern for payors. Most ER patients have low acuity. Build a triage process with the ER Department that makes after hour admissions seamless. The partnership that will bring you hydration patients will also bring you all of the TPN patients.

3. Health Plans are becoming more assertive in some urban areas in developing alternatives to the physician's oncology suite. Infusion Suite programs that include Hematopoietic Growth Factor Injectables (HGF) are very timely discussions. Many oncologists are now realizing that when these lower margin products aren't tying up their infusion clinic and A/R then sicker patients with more rofitable therapies can be seen more timely.

4. Pay for Performance contracting is common place with acute and rehab facilities. Health Plans are eager for ancillary arrangements  that will help reduce administrative costs such as maintaining a large network. Consider guaranteeing 100% admission on appropriate patients in certain counties in return for exclustivity.  

5. Health Plans push to increase sales just as your organization does. Meet with the plan's Sales Executives to partner on their key prospects. Insurance company underwriters rate and price based on the risk of each employer. Health Plans routinely work with acute care facilities to drive down risk that allows the plan to give a more competitive rate. Your Transplant and Inotropic programs could be the risk reducers that help the plan land their next big contract. Since you are tied into to the risk equation, they will not call any one else.

You have the programs, facilities and the people that bring strengths that differentiate you from the competition. By repackaging and presenting these benefits to payors you will avoid network termination, develop greater exclustivity and sell your services at a premium; all while sharing a WIN with the patient, the physician and the payor.

These proposals can be a bit intimidating if your managed care team doesn’t have much experience in developing these programs.

2020 ConsultRx is experienced at developing winning proposals and helping you implement them profitably. We can even assist you in getting the high level audience that you need at the payor level. Give me a call and let’s discuss how we can build your business today.

 


Download Article

Russell Gay


View all articles by Russell Gay


2020 ConsultRx, LLC


View all articles by 2020 ConsultRx, LLC

 
 


Copyright © 2010 Rock-Pond Solutions. All Rights Reserved.